IMM-1-104

· Immuneering Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMM-1-104, covering 2025-09-02 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]